Yurttutan Mehmet Emre, Tütüncüler Sancak Kevser, Tüzüner Ayşegül Mine
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ankara University, Ankara, Turkey.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ankara University, Ankara, Turkey.
J Oral Maxillofac Surg. 2019 Dec;77(12):2431-2438. doi: 10.1016/j.joms.2019.06.005. Epub 2019 Jun 19.
PURPOSE: The aim of the present study was to compare the efficacy of an occlusal splint and botulinum toxin for the treatment of bruxism. PATIENTS AND METHODS: Seventy-three patients with myofascial pain due to bruxism were included in the present study. The patients were allocated into 3 groups. Group A was treated with an occlusal splint, group B was treated with botulinum toxin injections, and group C was treated with an occlusal splint and botulinum toxin injections. The Temporomandibular Disorder Pain Screener, Graded Chronic Pain Scale, Oral Behavior Checklist, Jaw Function Limitation Scale, and visual analog scale (VAS) by palpation of the chewing muscles were administered to all patients before treatment and 6 months after treatment. RESULTS: The questionnaire and VAS scores decreased in all 3 groups (P < .0001). The VAS and questionnaire scores had decreased significantly in groups B and C compared with those in group A (mean VAS score: group A, 5 [range, 3 to 7]; group B, 1.9 ± 0.97; group C, 1.79 [range, 0 to 3]). CONCLUSIONS: Occlusal splints might not be necessary for patients treated with botulinum toxin injections.
目的：本研究旨在比较咬合板与肉毒杆菌毒素治疗磨牙症的疗效。 患者与方法：本研究纳入73例因磨牙症导致肌筋膜疼痛的患者。患者被分为3组。A组采用咬合板治疗，B组采用肉毒杆菌毒素注射治疗，C组采用咬合板和肉毒杆菌毒素注射治疗。在治疗前及治疗6个月后，对所有患者进行颞下颌关节紊乱疼痛筛查、慢性疼痛分级量表、口腔行为检查表、下颌功能受限量表以及通过触诊咀嚼肌的视觉模拟量表（VAS）评估。 结果：所有3组的问卷和VAS评分均下降（P <.0001）。与A组相比，B组和C组的VAS和问卷评分显著下降（平均VAS评分：A组为5[范围3至7]；B组为1.9±0.97；C组为1.79[范围0至3]）。 结论：接受肉毒杆菌毒素注射治疗的患者可能无需使用咬合板。
J Oral Maxillofac Surg. 2019-12
J Back Musculoskelet Rehabil. 2019
BMC Med Res Methodol. 2025-5-8
Curr Pediatr Rev. 2024
J Clin Med. 2023-7-10
Zotero 插件